Prostate Hyperplasia Clinical Trials

7 recruiting

Prostate Hyperplasia Trials at a Glance

9 actively recruiting trials for prostate hyperplasia are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Ankara, Boston, and Chicago. Lead sponsors running prostate hyperplasia studies include Beth Israel Deaconess Medical Center, Chinese University of Hong Kong, and Ankara Training and Research Hospital.

Browse prostate hyperplasia trials by phase

Treatments under study

About Prostate Hyperplasia Clinical Trials

Looking for clinical trials for Prostate Hyperplasia? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Prostate Hyperplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Prostate Hyperplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate

SurgeryProstate HyperplasiaEndoscopic Anatomical Enucleation of the Prostate (EEAP)
Fundacio Puigvert130 enrolled6 locationsNCT06649357
Recruiting

Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer (X-SMILE)

Prostate Cancer (Adenocarcinoma)Localized Prostate CarcinomaProstate Hyperplasia+1 more
University of Zurich75 enrolled3 locationsNCT06834152
Recruiting
Not Applicable

Early Versus Delayed Trial Without Catheter in Men With Acute Urinary Retention.

Acute Urinary RetentionBenign Prostate HyperplasiaBenign Prostate Obstruction+1 more
Liselot Ribbert478 enrolled11 locationsNCT07283484
Recruiting
Not Applicable

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

Prostate CancerIncontinence, Urinary StressBenign Prostate Hyperplasia
University of Rochester132 enrolled1 locationNCT07071207
Recruiting
Not Applicable

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Prostate HyperplasiaBenign Prostatic HyperplasiaLower Urinary Tract Symptoms+5 more
Beth Israel Deaconess Medical Center120 enrolled1 locationNCT04288427
Recruiting
Not Applicable

BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY

Prostate Hyperplasia
Chinese University of Hong Kong12 enrolled1 locationNCT05443451
Recruiting
Not Applicable

Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy

Prostate Hyperplasia
Ankara Training and Research Hospital82 enrolled1 locationNCT06865430
Recruiting
Not Applicable

Prostate Single Port & Laser Enucleation Comparison Trial

Prostate Hyperplasia
University of Illinois at Chicago116 enrolled1 locationNCT06224218
Recruiting

Prostate Metabolism, Cancer Risk and Gut Microbiota

Prostate CancerProstate Hyperplasia
Turku University Hospital300 enrolled2 locationsNCT06116851